Accelerating Open Biomedical Research

Home

Sage Bionetworks is a non-profit research organization that seeks to develop predictors of disease and accelerate health research through the creation of open systems, incentives, and standards. We create strategies and platforms that empower researchers to share and interpret data on a colossal scale, crowdsource tests for new hypotheses, and contribute to knowledge  through community challenges.

Current at Sage

Sage Bionetworks, in a broad partnership led by OHSU, has been awarded the new CTSA Program National Center for Data to Health (CD2H). This award will coalesce and coordinate informatics activities across the Clinical and Translational Science Award (CTSA) Program, a network of more than 50 medical research institutions, to provide collaborative clinical and translational research infrastructure.
Sage Bionetworks and the Institute for Systems Biology will partner to build the Cancer Research Institute iAtlas, an online database and web resource designed to help basic and clinical researchers navigate immunological data across multiple tumor types. The CRI iAtlas database is the first comprehensive effort in immuno-oncology to address the recent National Cancer Moonshot Blue Ribbon Panel recommendation to establish a pan-cancer immune atlas that would help catalyze new research in cancer immunotherapy.
A new cancer neoantigen discovery alliance led by the Parker Institute for Cancer Immunotherapy and the Cancer Research Institute is bringing together 30 leading research groups to help develop more effective personalized cancer vaccines for patients faster. Sage Bionetworks will lead the bioinformatics and data analysis effort.
As part of the most ambitious medical research program in the history of American medicine, The Scripps Research Institute (TSRI) and its partners including Sage Bionetworks have received an initial award of $20M for their role in President Obama’s national All of Us Research Program. This landmark longitudinal research effort will leverage smart phones and other personal technologies to engage one million or more U.S. participants to improve the ability to prevent and treat disease based on individual differences in lifestyle, environment and genetics.

News

August 21, 2017

Novartis launches elevateMS developed together with Sage – the first large-scale research study in MS allowing participants to contribute from smartphones Full Article

August 14, 2017

Sage Bionetworks and Celgene Corporation launch Journey PRO, a mobile health research study to improve lives of patients living with chronic anemia Full Article

July 20, 2017

Progress is being made in the use of personalized approaches to create both in vitro and in vivo tumour models Full Article

July 10, 2017

DREAM Challenge Community competition launches to learn how to use smartphone and wearable sensors to monitor health Full Article

Work with us.

Sage was recently ranked as the 2nd best place to work in academia. We invite you to make an impact on research and technology by being a part of our integrated group of computational biologists, clinicians, and software engineers . MORE

Sage Bionetworks’ Current Funding Partners include: